Jiangsu Nanfang Medical Total Liabilities
Jiangsu Nanfang Medical total liabilities. Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has total liabilities worth CN¥711.34 Million CNY (≈ $104.09 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Jiangsu Nanfang Medical to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jiangsu Nanfang Medical (2012–2025)
Total liabilities of Jiangsu Nanfang Medical from 2012 to 2025. This chart illustrates how Jiangsu Nanfang Medical's total liabilities have evolved over time, based on quarterly financial data.
Jiangsu Nanfang Medical Competitors by Total Liabilities
The table below lists competitors of Jiangsu Nanfang Medical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Symtek Automation Asia Co Ltd
TW:6438
|
Taiwan | NT$4.76 Billion |
|
Taiwan Paiho Ltd
TW:9938
|
Taiwan | NT$17.22 Billion |
|
Orchestra BioMed Holdings Inc.
NASDAQ:OBIO
|
USA | $86.28 Million |
|
John Marshall Bancorp Inc
NASDAQ:JMSB
|
USA | $2.13 Billion |
|
Aurora Cannabis Inc
TO:ACB
|
Canada | CA$93.75 Million |
|
ADTRAN Inc
NASDAQ:ADTN
|
USA | $678.52 Million |
|
Peijia Medical Limited
F:4WO
|
Germany | €798.71 Million |
|
eMudhra Limited
NSE:EMUDHRA
|
India | Rs2.63 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Jiangsu Nanfang Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603880 asset base.
Liquidity & Leverage Metrics
Jiangsu Nanfang Medical Total Liabilities Ratios Explained
Jiangsu Nanfang Medical total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Nanfang Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Nanfang Medical (2012–2025)
The table below shows the annual total liabilities of Jiangsu Nanfang Medical from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥746.77 Million ≈ $109.28 Million |
-3.29% |
| 2024-12-31 | CN¥772.14 Million ≈ $112.99 Million |
-3.86% |
| 2023-12-31 | CN¥803.11 Million ≈ $117.52 Million |
-3.91% |
| 2022-12-31 | CN¥835.75 Million ≈ $122.30 Million |
+44.02% |
| 2021-12-31 | CN¥580.29 Million ≈ $84.92 Million |
+56.06% |
| 2020-12-31 | CN¥371.84 Million ≈ $54.41 Million |
+23.09% |
| 2019-12-31 | CN¥302.08 Million ≈ $44.20 Million |
+5.70% |
| 2018-12-31 | CN¥285.78 Million ≈ $41.82 Million |
+0.13% |
| 2017-12-31 | CN¥285.40 Million ≈ $41.76 Million |
+9.82% |
| 2016-12-31 | CN¥259.87 Million ≈ $38.03 Million |
+3.59% |
| 2015-12-31 | CN¥250.86 Million ≈ $36.71 Million |
+10.95% |
| 2014-12-31 | CN¥226.10 Million ≈ $33.09 Million |
+10.41% |
| 2013-12-31 | CN¥204.78 Million ≈ $29.97 Million |
-20.75% |
| 2012-12-31 | CN¥258.41 Million ≈ $37.81 Million |
-- |
About Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of transdermal products, medical adhesive tapes and bandages, sports protective equipment, first aid kits, nitrile gloves, and protective equipment in China and internationally. The company offers medical proof fabrics, care products, band-aids, and applications; medical w… Read more